(Q43762464)

26 November 2017

title

Women and cardiovascular risk (English)

1 reference

26 November 2017

Welty FK

1

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

American Journal of Cardiology

26 November 2017

published in

1 reference

26 November 2017

volume

88

1 reference

26 November 2017

issue

7B

1 reference

26 November 2017

page(s)

48J-52J

1 reference

Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS)

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

Effect of gender on long-term outcome of angina pectoris and myocardial infarction/sudden unexpected death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901884-7

10.1016/S0002-9149(01)01884-7

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference